TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PTCT

PTC Therapeutics Inc

Healthcare · Biotechnology

62.30$ -5.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

PTC Therapeutics Inc (PTCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 361 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PTCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
197 307 210 187 197 213 1,176 179 211 165 273 361 1,009
9.5 106 15 16 11 16 13 11 116 16 28 20 180
187 201 195 171 186 197 1,163 167 95 148 245 341 829
164 121 116 132 161 125 109 113 100 133 101 99 433
81 81 73 70 73 85 81 85 84 97 86 81 348
305 198 241 211 240 359 193 202 92 230 199 192 712
-118 3.1 -45 -40 -55 -162 970 -35 3.0 -82 46 149 116
28 44 41 43 42 41 34 30 33 55 49 48 185
-167 -157 -85 -86 -98 -95 930 -71 -23 -139 -2.5 98 -67
-34 -1.3 6.9 13 8.7 -29 63 -6.2 -39 -4.1 0.3 14 -29
-133 -156 -92 -99 -107 -66 867 -65 16 -135 -2.8 83 -38
-74 -32 12 -35 -50 -47 971 -33 21 -71 62 162 174

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?